Fresenius Medical Valuation
| FMS Stock | USD 24.26 0.36 1.46% |
At this time, the firm appears to be overvalued. Fresenius Medical Care shows a prevailing Real Value of $22.23 per share. The current price of the firm is $24.26. Our model computes the value of Fresenius Medical Care from reviewing the firm fundamentals such as Profit Margin of 0.03 %, shares outstanding of 586.83 M, and Current Valuation of 24.64 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Fresenius Medical's price fluctuation is very steady at this time. Calculation of the real value of Fresenius Medical Care is based on 3 months time horizon. Increasing Fresenius Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Fresenius stock is determined by what a typical buyer is willing to pay for full or partial control of Fresenius Medical Care. Since Fresenius Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fresenius Stock. However, Fresenius Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.26 | Real 22.23 | Hype 24.26 | Naive 24.37 |
The intrinsic value of Fresenius Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fresenius Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fresenius Medical Care helps investors to forecast how Fresenius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fresenius Medical more accurately as focusing exclusively on Fresenius Medical's fundamentals will not take into account other important factors: Fresenius Medical Total Value Analysis
Fresenius Medical Care is currently expected to have company total value of 24.64 B with market capitalization of 14.53 B, debt of 10.98 B, and cash on hands of 362.77 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Fresenius Medical fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.64 B | 14.53 B | 10.98 B | 362.77 M |
Fresenius Medical Investor Information
The company has price-to-book (P/B) ratio of 0.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 0.49. The entity last dividend was issued on the 17th of May 2024. The firm had 2:1 split on the 4th of December 2012. Fresenius Medical Care is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in April.Fresenius Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fresenius Medical has an asset utilization ratio of 57.6 percent. This implies that the Company is making $0.58 for each dollar of assets. An increasing asset utilization means that Fresenius Medical Care is more efficient with each dollar of assets it utilizes for everyday operations.Fresenius Medical Ownership Allocation
Fresenius Medical holds a total of 586.83 Million outstanding shares. Roughly 93.0 percent of Fresenius Medical outstanding shares are held by general public with 7.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Fresenius Medical Profitability Analysis
The company reported the last year's revenue of 19.34 B. Total Income to common stockholders was 740.87 M with profit before taxes, overhead, and interest of 4.76 B.Fresenius Medical Past Distributions to stockholders
About Fresenius Medical Valuation
The stock valuation mechanism determines Fresenius Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Fresenius Medical Care based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fresenius Medical. We calculate exposure to Fresenius Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fresenius Medical's related companies.KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States.
A single share of Fresenius Medical represents a small ownership stake in the entity. As a stockholder of Fresenius, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Fresenius Medical Dividends Analysis For Valuation
Please note that Fresenius Medical has scaled down on payment of dividends at this time.
There are various types of dividends Fresenius Medical can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Fresenius shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Fresenius Medical Care directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Fresenius pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Fresenius Medical by the value of the dividends paid out.
Fresenius Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Fresenius Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 293.4 M | |
| Quarterly Earnings Growth Y O Y | -0.656 | |
| Forward Price Earnings | 12.21 |
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.